Skip to main content
NPNeptune Insurance Holdings Inc.Sell5.1·$29.68-2.18%
NP · Why this verdict

Why Neptune Insurance Holdings (NP) is rated SELL

Updated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

VerdictSELL
Overall score5.1/10
ConfidenceMEDIUM
MacroNEUTRAL
TrendMatrix Research · core thesis

Engine thesis — one sentence

Neptune Insurance Holdings is a high-quality insurance broker with strong margins and a Piotroski F-Score of 8 out of 9, but its expensive forward P/E of 43x, price already above analyst targets, and heavy reliance on insurance agent and broker partners create meaningful near-term risk.

Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.

Thesis pillars

Neptune has a Piotroski F-Score of 8 out of 9 with 21% operating margins, placing it in the high-quality tier of insurance broker peers, and a Moat score of 7.0 indicating meaningful competitive positioning in its specialty insurance market.

Stable
Quality breakdown
Expectation
Piotroski F-Score remains at 7 or above and operating margins stay above 18% over the next 12 months.

CounterA quality score of 7.8 is strong but the earnings history shows a recent miss and two inline results, indicating revenue and earnings predictability are lower than the quality score implies.

At a forward P/E of 43x, Neptune is priced as a high-growth technology company rather than an insurance broker, and with revenue growing at 29%, the PEG ratio is compressed but the absolute multiple leaves very little margin for disappointment.

Improving
Valuation breakdown
Expectation
Revenue growth sustains above 20% for at least 3 of the next 4 quarters to justify the premium valuation.

CounterInsurance distribution platforms can command technology-like multiples if they demonstrate network effects and recurring revenue characteristics that traditional insurance brokers lack.

Neptune's revenue is significantly dependent on its insurance agent and broker partner network, meaning any deterioration in partner relationships, competitive displacement, or commission rate compression could materially reduce revenue without warning.

Deteriorating
Bear case
Expectation
Revenue retention from existing partners remains above 90% over the next 12 months, indicating stable partner relationships.

CounterInsurance brokers that embed deeply into the agency workflow tend to have very high switching costs, and the 29% revenue growth suggests the partner network is actively expanding rather than at risk.

The current price of $27.56 is approximately 4% above the analyst consensus price target, meaning the market has already fully priced in analyst expectations and any negative surprise could lead to a significant price correction given the high multiple.

Deteriorating
Warnings
Expectation
Analyst consensus price target is revised above $30 within 6 months as revenue growth is sustained.

CounterStrong volume accumulation with rising on-balance volume and a momentum score of 6.4 above the threshold suggest institutional buying interest that could carry the price higher despite the modest overvaluation signal.

Per-dimension breakdown

Value

1.9/10data confidence 50%
ComponentSub-score
P/S0.0
Fwd P/E2.5
Analyst target4.0
  • Forward P/E: 46.6x
  • Expensive valuation

Quality

7.8/10data confidence 86%
ComponentSub-score
Gross margin7.0
Op margin10.0
Net margin10.0
Current ratio4.0
Moat7.0
Piotroski F8.9
  • Strong margins: 21%
  • Strong Piotroski F-Score: 8/9
  • High-quality business

Growth

6.1/10data confidence 67%
ComponentSub-score
Rev growth9.7
EPS growth2.6
  • Strong growth: 29% YoY

Momentum

3.0/10data confidence 100%
ComponentSub-score
RSI8.2
MACD0.0
OBV1.0
MA position6.0
Volume0.0
  • Oversold in uptrend (RSI 27)
  • Volume distribution (falling OBV)
  • Above 200-day MA

Sentiment

6.5/10data confidence 100%
ComponentSub-score
LLM sentiment5.9
Analyst rating7.2
Price target6.4

Insider

5.2/10data confidence 100%
ComponentSub-score
materiality2.0
insider conviction2.0
holder change10.0
notable moves7.0
  • Heavy insider selling — $298,784,746 (7.119% of mkt cap)
  • Institutions accumulating

Peer rank

5.0/10data confidence 80%
ComponentSub-score
value rank0.0
quality rank8.5
growth rank6.4
  • Best-in-class margins

Technical

6.2/10data confidence 100%
ComponentSub-score
bollinger7.6
support resistance6.9
52w position7.1
gap3.0
  • Extreme gap up (6.7%) - may pull back

Risk (lower is worse)

5.0/10data confidence 60%
ComponentSub-score
short interest6.2
days to cover8.7
volatility0.0
  • Concentration risks: 1 HIGH (10-K Item 1A — sized via position_sizing, validated via buy_confidence)

Catalyst

4.0/10data confidence 100%
ComponentSub-score
erm5.0
earnings history0.0
surprise avg2.9
news activity8.0

How the verdict was assembled

Engine trigger

Multiple concerning factors. Consider reducing position.

Engine technical detail
verdict_path: L4:PATH_F_SELL
Passed (4)
  • 8K:CLEAN
  • EARNINGS_PROXIMITY:NO_DATE
  • SEMI_CYCLE_PEAK:CLEAR
  • MATERIALS_CYCLE_PEAK:CLEAR
Failed (3)
  • MOMENTUM:3.0<4.5
  • ASYMMETRY:-0.4=NEGATIVE
  • INSIDER:7.12%=EXTREME
Warning (0)

none

Reward-to-Risk
-0.41
Upside
-4.8%
Downside
11.6%
Sizing output
AVOID

Setup No clear chart pattern; technical signals are mixed

EdgeTemporary headwind High quality (7.8) with weak momentum (3.0)

SuitabilityAggressive MCap $4.2B<$5B

Investment implication

The F-path SELL output reflects an overall score of 5.1 below the 5.6 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. The strongest dimension ( Quality at 7.8) was not enough to lift the adjusted overall above the threshold. Co-occurring failed gates ( MOMENTUM:3.0<4.5, ASYMMETRY:-0.4=NEGATIVE, INSIDER:7.12%=EXTREME) reinforce the read. Current asymmetry R:R is -0.41 — supplementary context, not the trigger for this path.

The strongest dimensions are Quality at 7.8, Sentiment at 6.5, and Technical at 6.2; the weakest are Value at 1.9, Momentum at 3.0, and Catalyst at 4.0. The V9 engine flagged 3 failed gates, producing an asymmetric reward-to-risk of -0.41 and an engine sizing output of AVOID.

What would invalidate the thesis

Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.

  • P1High Quality Business Profile

    Trip ifPiotroski F-Score falls below 6 or operating margins fall below 15% for 2 consecutive quarters.

  • P2Expensive Valuation Multiple

    Trip ifRevenue growth falls below 15% year-over-year for 2 consecutive quarters while the forward P/E remains above 35x.

  • P3Partner Concentration Risk

    Trip ifAny disclosed partner representing more than 10% of revenue announces a competing product or contract termination.

  • P4Price Above Analyst Target

    Trip ifPrice rises above $33 while analyst consensus target remains below $29.

Engine reasoning is mechanically derived from pipeline gate outputs. See decision view.

Home Stocks NP Why this verdict